Target Price | $2.25 |
Price | $0.10 |
Potential |
2,219.59%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Cns Pharmaceuticals Inc 2026 .
The average Cns Pharmaceuticals Inc target price is $2.25.
This is
2,219.59%
register free of charge
$4.00
4,023.71%
register free of charge
$0.50
415.46%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Cns Pharmaceuticals Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Cns Pharmaceuticals Inc stock has an average upside potential 2026 of
2,219.59%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -250.19 | -0.86 |
55.39% | 99.66% | |
P/E | negative |
2 Analysts have issued a Cns Pharmaceuticals Inc forecast for earnings per share. The average Cns Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Cns Pharmaceuticals Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.